Zealand Pharma A/S (ZEAL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.070x

Based on the latest financial reports, Zealand Pharma A/S (ZEAL) has a cash flow conversion efficiency ratio of -0.070x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-1.04 Billion ≈ $-163.16 Million USD) by net assets (Dkr14.83 Billion ≈ $2.32 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zealand Pharma A/S - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Zealand Pharma A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ZEAL total debt and obligations for a breakdown of total debt and financial obligations.

Zealand Pharma A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zealand Pharma A/S ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Camurus AB ST:CAMX	0.060x
The Marzetti Company NASDAQ:MZTI	0.086x
Organización Soriana S. A. B. de C. V MX:SORIANAB	0.047x
ChengDu Hi-Tech Development Co Ltd SHE:000628	0.041x
LIFE360 Inc AU:360	0.069x
Shanghai Jin Jiang International Hotels Development Co Ltd A SHG:600754	0.092x
Jubilant Foodworks Limited NSE:JUBLFOOD	0.403x
MiTAC Holdings Corp TW:3706	0.045x

Annual Cash Flow Conversion Efficiency for Zealand Pharma A/S (2007–2025)

The table below shows the annual cash flow conversion efficiency of Zealand Pharma A/S from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Zealand Pharma A/S (ZEAL) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr14.83 Billion ≈ $2.32 Billion	Dkr6.53 Billion ≈ $1.02 Billion	0.440x	+507.72%
2024-12-31	Dkr8.62 Billion ≈ $1.35 Billion	Dkr-930.82 Million ≈ $-145.63 Million	-0.108x	+59.58%
2023-12-31	Dkr1.59 Billion ≈ $249.21 Million	Dkr-425.67 Million ≈ $-66.60 Million	-0.267x	+76.86%
2022-12-31	Dkr815.91 Million ≈ $127.66 Million	Dkr-942.21 Million ≈ $-147.42 Million	-1.155x	+11.60%
2021-12-31	Dkr927.80 Million ≈ $145.16 Million	Dkr-1.21 Billion ≈ $-189.62 Million	-1.306x	-123.26%
2020-12-31	Dkr1.18 Billion ≈ $184.16 Million	Dkr-688.72 Million ≈ $-107.75 Million	-0.585x	-77.57%
2019-12-31	Dkr1.24 Billion ≈ $194.43 Million	Dkr-409.45 Million ≈ $-64.06 Million	-0.329x	+20.11%
2018-12-31	Dkr1.12 Billion ≈ $174.65 Million	Dkr-460.40 Million ≈ $-72.03 Million	-0.412x	+21.81%
2017-12-31	Dkr528.47 Million ≈ $82.68 Million	Dkr-278.75 Million ≈ $-43.61 Million	-0.527x	-458.73%
2016-12-31	Dkr278.19 Million ≈ $43.53 Million	Dkr40.90 Million ≈ $6.40 Million	0.147x	+116.45%
2015-12-31	Dkr252.23 Million ≈ $39.46 Million	Dkr-225.41 Million ≈ $-35.27 Million	-0.894x	-435.63%
2014-12-31	Dkr252.83 Million ≈ $39.56 Million	Dkr-42.18 Million ≈ $-6.60 Million	-0.167x	+68.90%
2013-12-31	Dkr316.14 Million ≈ $49.46 Million	Dkr-169.62 Million ≈ $-26.54 Million	-0.537x	-484.38%
2012-12-31	Dkr491.01 Million ≈ $76.82 Million	Dkr68.54 Million ≈ $10.72 Million	0.140x	+3511.47%
2011-12-31	Dkr441.40 Million ≈ $69.06 Million	Dkr-1.81 Million ≈ $-282.56K	-0.004x	+97.02%
2010-12-31	Dkr407.11 Million ≈ $63.70 Million	Dkr-55.98 Million ≈ $-8.76 Million	-0.138x	+70.26%
2009-12-31	Dkr132.92 Million ≈ $20.80 Million	Dkr-61.45 Million ≈ $-9.61 Million	-0.462x	-237.00%
2008-12-31	Dkr208.63 Million ≈ $32.64 Million	Dkr-28.62 Million ≈ $-4.48 Million	-0.137x	+42.25%
2007-12-31	Dkr242.37 Million ≈ $37.92 Million	Dkr-57.57 Million ≈ $-9.01 Million	-0.238x	--

About Zealand Pharma A/S

CO:ZEAL Denmark Biotechnology

Market Cap

$3.41 Billion

Dkr21.77 Billion DKK

Market Cap Rank

#4569 Global

#26 in Denmark

Share Price

Dkr309.00

Change (1 day)

+3.21%

52-Week Range

Dkr234.90 - Dkr545.80

All Time High

Dkr954.00